Zhejiang Medicine Co (SHSE:600216) Total Liabilities : ¥2,820 Mil (As of Sep. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Zhejiang Medicine Co Total Liabilities?

Zhejiang Medicine Co's Total Liabilities for the quarter that ended in Sep. 2024 was ¥2,820 Mil.

Zhejiang Medicine Co's quarterly Total Liabilities declined from Mar. 2024 (¥2,843.31 Mil) to Jun. 2024 (¥2,633.12 Mil) but then increased from Jun. 2024 (¥2,633.12 Mil) to Sep. 2024 (¥2,820.11 Mil).

Zhejiang Medicine Co's annual Total Liabilities declined from Dec. 2021 (¥3,350.24 Mil) to Dec. 2022 (¥2,722.76 Mil) but then increased from Dec. 2022 (¥2,722.76 Mil) to Dec. 2023 (¥2,793.15 Mil).

Zhejiang Medicine Co Total Liabilities Historical Data

The historical data trend for Zhejiang Medicine Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Medicine Co Total Liabilities Chart

Zhejiang Medicine Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

2,110.16

2,470.42

3,350.24

2,722.76

2,793.15

Zhejiang Medicine Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															2,693.54	2,793.15	2,843.31	2,633.12	2,820.11

Zhejiang Medicine Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Zhejiang Medicine Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2478.442	+	(230.546	+	84.158
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	2,793

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	12779.54	-	9986.394
	=	2,793

Zhejiang Medicine Co's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2358.145	+	(372.842	+	89.124
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	2,820

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	13429.512	-	10609.401
	=	2,820

Zhejiang Medicine Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Zhejiang Medicine Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Medicine Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Medicine Co Ltd (SHSE:600216) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

Comprehensive Building, No. 398 Mahuan Road, 3rd Floor, Building A, Binhai New City, Shaoxing, CHN, 312366

Website

http://www.china-zmc.com

Zhejiang Medicine Co Ltd is a china-based pharmaceutical company. The company manufactures fat-soluble vitamins, vitamins, quinolones, and antibiotic-resistant antibiotics, vitamin E, natural vitamin E, beta-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin.

Executives

Zhu Jin Lin	senior management
Chu Zhen Hua	Director
Liang Bi Rong	Director
Yu Yu Qing	Director
Ping Jian Hong	senior management
An Yong Bin	senior management
Wang Xiao Ping	senior management
Liang Li Ping	senior management
Li Qi Rong	senior management
Zhu Shao Ming	Supervisors
Wang Hong Wei	senior management
Zhang Ding Feng	senior management
Ma Wen Xin	Director
Zhao Jun Xing	senior management
Lv Yong Hui	Director

Zhejiang Medicine Co Headlines

No Headlines